Article info

Download PDFPDF

Extended report
Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors
Free

Authors

  1. Correspondence to Dr Mark Genovese, Division of Immunology and Rheumatology, Stanford University, 1000 Welch Rd #203, Palo Alto, CA 94304, USA; Genovese{at}Stanford.edu
View Full Text

Citation

Genovese MC, Fleischmann RM, Greenwald M, et al
Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors

Publication history

  • Received October 3, 2012
  • Revised November 21, 2012
  • Accepted November 27, 2012
  • First published December 25, 2012.
Online issue publication 
August 06, 2013

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.